Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing.
Huang L, Lou N, Xie T, Tang L, Han X, Shi Y. Huang L, et al. Among authors: lou n. Cancer Immunol Immunother. 2023 Oct;72(10):3259-3277. doi: 10.1007/s00262-023-03485-5. Epub 2023 Jul 17. Cancer Immunol Immunother. 2023. PMID: 37458771 Free PMC article.
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray.
Dai L, Chen H, Tan Q, Wang Y, Li L, Lou N, Fan G, Xie T, Luo R, Wang S, Zhou Y, Zhong Q, Yao J, Zhang Z, Tang L, Shi Y, Han X. Dai L, et al. Among authors: lou n. Cancer. 2024 Apr 15;130(8):1257-1269. doi: 10.1002/cncr.35158. Epub 2023 Dec 22. Cancer. 2024. PMID: 38133926
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer.
Dai L, Tan Q, Li L, Lou N, Zheng C, Yang J, Huang L, Wang S, Luo R, Fan G, Xie T, Yao J, Zhang Z, Tang L, Shi Y, Han X. Dai L, et al. Among authors: lou n. Mol Cell Proteomics. 2024 May;23(5):100749. doi: 10.1016/j.mcpro.2024.100749. Epub 2024 Mar 20. Mol Cell Proteomics. 2024. PMID: 38513890 Free PMC article.
Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data.
Lou N, Cui X, Lin X, Gao R, Xu C, Qiao N, Jiang J, Wang L, Wang W, Wang S, Shen W, Zheng X, Han X. Lou N, et al. Transl Lung Cancer Res. 2024 Apr 29;13(4):706-720. doi: 10.21037/tlcr-23-737. Epub 2024 Apr 24. Transl Lung Cancer Res. 2024. PMID: 38736496 Free PMC article.
168 results